We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.06B
Cap. Flow
-$252M
Cap. Flow %
-1.29%
Top 10 Hldgs %
27.73%
Holding
2,867
New
60
Increased
922
Reduced
1,499
Closed
102

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.2M
2
NVDA icon
NVIDIA
NVDA
+$28.8M
3
SNV
Synovus
SNV
+$21M
4
AUB icon
Atlantic Union Bankshares
AUB
+$20.5M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 12.71%
3 Industrials 10.47%
4 Healthcare 10.16%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERII icon
2051
Energy Recovery
ERII
$410M
$276K ﹤0.01%
27,415
+2,747
+11% +$35.9K
IVR icon
2052
Invesco Mortgage Capital
IVR
$764M
$276K ﹤0.01%
34,158
-5,774
-14% -$49.3K
SPRY icon
2053
ARS Pharmaceuticals
SPRY
$573M
$276K ﹤0.01%
34,338
TEM
2054
Tempus AI
TEM
$7.53B
$275K ﹤0.01%
6,081
-122
-2% -$6.93K
BAND
2055
Bandwidth Inc
BAND
$1.19B
$275K ﹤0.01%
15,426
-370
-2% -$5.42K
CRMD icon
2056
CorMedix
CRMD
$564M
$274K ﹤0.01%
40,399
-870
-2% -$6.43K
FOR icon
2057
Forestar Group
FOR
$1.47B
$274K ﹤0.01%
11,222
NUTX
2058
Nutex Health
NUTX
$975M
$274K ﹤0.01%
2,884
+755
+35% +$92.6K
BETA
2059
Beta Technologies Inc
BETA
$3.93B
$274K ﹤0.01%
+18,643
New +$382K
LBRX
2060
LB Pharmaceuticals
LBRX
$1.08B
$274K ﹤0.01%
11,104
WLFC icon
2061
Willis Lease Finance
WLFC
$1.65B
$273K ﹤0.01%
4,815
HIPO icon
2062
Hippo Holdings
HIPO
$774M
$273K ﹤0.01%
10,463
-189
-2% -$5.38K
AIP icon
2063
Arteris
AIP
$1.26B
$273K ﹤0.01%
16,582
-369
-2% -$5.85K
BSRR icon
2064
Sierra Bancorp
BSRR
$535M
$273K ﹤0.01%
8,035
CPS icon
2065
Cooper-Standard Automotive
CPS
$536M
$272K ﹤0.01%
9,744
FCNCA icon
2066
First Citizens BancShares
FCNCA
$24.9B
$271K ﹤0.01%
144
-4
-3% -$8.03K
NB
2067
NioCorp Developments
NB
$572M
$271K ﹤0.01%
60,839
ROKU icon
2068
Roku
ROKU
$21.5B
$271K ﹤0.01%
2,867
-48
-2% -$4.67K
RVMD icon
2069
Revolution Medicines
RVMD
$38.6B
$271K ﹤0.01%
2,788
-750
-21% -$75.7K
SABR icon
2070
Sabre
SABR
$712M
$271K ﹤0.01%
186,762
+29,834
+19% +$39.7K
ACEL icon
2071
Accel Entertainment
ACEL
$995M
$270K ﹤0.01%
24,779
-4,256
-15% -$48K
VITL icon
2072
Vital Farms
VITL
$590M
$269K ﹤0.01%
19,086
-199
-1% -$4.7K
HTFL
2073
Heartflow Inc
HTFL
$2.17B
$268K ﹤0.01%
11,035
KRUS icon
2074
Kura Sushi USA
KRUS
$587M
$268K ﹤0.01%
3,842
APLS
2075
DELISTED
Apellis Pharmaceuticals
APLS
$267K ﹤0.01%
6,633
-329
-5% -$7.09K

Similar funds

MetLife Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, MetLife Investment Management held 2,867 positions worth $19.6B, down 5.1% from $20.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

MetLife Investment Management's Q1 2026 filing shows 60 new, 922 increased, 1,499 reduced and 102 closed positions. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M. The largest sale was Apple, an estimated $32.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

  • MetLife Investment Management's largest Q1 2026 buy was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $62.3M increase.
  • MetLife Investment Management's biggest Q1 2026 reduction was Apple, cutting an estimated $32.2M.
  • MetLife Investment Management fully exited Synovus in Q1 2026, selling an estimated $21M.
  • MetLife Investment Management's ten largest holdings make up 28% of its $19.6B portfolio in Q1 2026.
  • MetLife Investment Management opened 60 new positions and closed 102 in Q1 2026.
  • MetLife Investment Management's portfolio value fell 5.1% quarter-over-quarter to $19.6B.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.